Tufts won approval three years ago to become a level two trauma center. Before then, Tufts was the only major Boston teaching hospital not approved as an adult trauma center.
As a result, ambulances carrying victims of car accidents, falls, or violence often bypassed that hospital for Beth Israel Deaconess Medical Center, Boston Medical Center, Brigham and Women’s Hospital, or Massachusetts General Hospital - all state-designated trauma centers.
Now, Tufts wants to take its role a step further. The hospital has asked the American College of Surgeons to designate it as a level one trauma center. The state Department of Public Health must give final approval.
“Level one tells the community and referring physicians and hospitals we really have met the highest standard,’’ said Dr. Brien Barnewolt, head of emergency medicine. “We’re proud of that.’’
But in a letter last week to John Auerbach, Massachusetts public health commissioner, surgery chiefs at the four other hospitals argued that designating a fifth level one trauma center in the city could harm public health by diluting physician and staff expertise.
Dr. Keith Lillemoe, surgery chief at Mass. General, said adding a level one trauma center in Boston doesn’t seem like the best use of resources, particularly since some other regions of the state have thin trauma coverage. “Why doesn’t someone look at what we really need?’’ he asked.
The surgery chiefs - including Dr. Michael Zinner at the Brigham, Dr. Gerard Doherty at Boston Medical Center, and Dr. Elliot Chaikof at Beth Israel Deaconess - asked the health department to delay its decision until the American College of Surgeons finishes an assessment of the state trauma system, which was commissioned by the health department.
Barnewolt called the letter “a little self-serving. If we have met the criteria, there’s really no reason to wait,’’ he said.
Madeleine Biondolillo, director of health care safety and quality for the health department, said in a written statement: “The Department awaits the determination of the ACS review and cannot comment further at this time.’’
More coverage, more cost